Investment Thesis
Ardelyx exhibits severe operational challenges with massive losses despite 22% revenue growth, indicating poor unit economics and inability to monetize sales effectively. The company faces critical cash burn (-$44M FCF) with only 68M cash reserves against 202.8M long-term debt, creating near-term solvency concerns unless losses narrow significantly.
ARDX Strengths
- Strong revenue growth of 22.1% year-over-year demonstrates market demand for products
- Solid liquidity position with 4.31x current ratio provides near-term operational flexibility
- Positive insider activity with 20 Form 4 filings in last 90 days suggests management confidence
ARDX Risks
- Catastrophic profitability with -15.1% net margin and operating losses of $41M despite $407M revenue indicates fundamental business model problems
- Negative free cash flow of $44M annually is unsustainable; at current burn rate, cash reserves could deplete within 1-2 years without additional financing
- Excessive leverage with 1.21x debt-to-equity ratio and $202.8M long-term debt against $68M cash creates significant refinancing risk
- Deteriorating EPS trend (-52.9% YoY) despite revenue growth signals worsening operational performance
- Negative interest coverage of -17.4x indicates company cannot service debt from operations
Key Metrics to Watch
- Operating cash flow trend - critical to determine if losses are stabilizing or accelerating
- Gross margin expansion - 1.1% is abnormally low and must improve for viability
- Debt refinancing schedule and covenant compliance - essential given high leverage and negative EBITDA
- Path to profitability timeline - company must demonstrate realistic turnaround plan
ARDX Financial Metrics
ARDX Profitability Ratios
ARDX Balance Sheet & Liquidity
ARDX 5-Year Financial Trend
5-Year Trend Summary: ARDELYX, INC.'s revenue has grown significantly by 3,934% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.30 indicates the company is currently unprofitable.
ARDX Growth Metrics (YoY)
ARDX Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $98.2M | -$809.0K | $0.00 |
| Q2 2025 | $73.2M | -$16.5M | $-0.07 |
| Q1 2025 | $46.0M | -$26.5M | $-0.11 |
| Q3 2024 | $56.4M | -$809.0K | $0.00 |
| Q2 2024 | $22.3M | -$16.5M | $-0.07 |
| Q1 2024 | $11.4M | -$26.5M | $-0.11 |
| Q3 2023 | $5.0M | $6.6M | $0.03 |
| Q2 2023 | $2.5M | -$17.1M | $-0.08 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ARDX Capital Allocation
ARDX SEC Filings
Access official SEC EDGAR filings for ARDELYX, INC. (CIK: 0001437402)